focus -WSS

focus

author：focus 2025-10-02 16:48:48 Page View：5669

Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.

To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： For Medicare Advantage, Democrats want stronger protections around AI
Next article： How one medical school became remarkably diverse

focus

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Medicare threatens to cut off funding for HCA's Mission hospital

MikeBellemeforSTATFiveyearsafterinvestor-ownedHCAHealthcaretookoveranesteemednonprofithospitalinNort

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

U.K. considers world's first use of meningitis vaccine to address gonorrhea

ColorizedscanningelectronmicrographofNeisseriagonorrhoeaebacteria,whichcausesgonorrhea.NIAIDAnexpert

focus

leisure time

focus

U.K. considers world's first use of meningitis vaccine to address gonorrhea